Jump to content

Ceramide

From Wikipedia, the free encyclopedia
(Redirected from Proapoptotic ceramide)
Ceramide. R represents the alkyl portion of a fatty acid.
General structures of sphingolipids

Ceramides are a family of waxy lipid molecules. A ceramide is composed of sphingosine and a fatty acid joined by an amide bond. Ceramides are found in high concentrations within the cell membrane of eukaryotic cells, since they are component lipids that make up sphingomyelin, one of the major lipids in the lipid bilayer.[1] Contrary to previous assumptions that ceramides and other sphingolipids found in cell membrane were purely supporting structural elements, ceramide can participate in a variety of cellular signaling: examples include regulating differentiation, proliferation, and programmed cell death (PCD) of cells.

The word ceramide comes from the Latin cera (wax) and amide. Ceramide is a component of vernix caseosa, the waxy or cheese-like white substance found coating the skin of newborn human infants.

Pathways for ceramide synthesis

[edit]

There are three major pathways of ceramide generation. First, the sphingomyelinase pathway uses an enzyme to break down sphingomyelin in the cell membrane and release ceramide. Second, the de novo pathway creates ceramide from less complex molecules. Third, in the "salvage" pathway, sphingolipids that are broken down into sphingosine are reused by reacylation to form ceramide.

Sphingomyelin hydrolysis

[edit]

Hydrolysis of sphingomyelin is catalyzed by the enzyme sphingomyelinase. Because sphingomyelin is one of the four common phospholipids found in the plasma membrane of cells, the implications of this method of generating ceramide is that the cellular membrane is the target of extracellular signals leading to programmed cell death. There has been research suggesting that when ionizing radiation causes apoptosis in some cells, the radiation leads to the activation of sphingomyelinase in the cell membrane and ultimately, to ceramide generation.[2]

De novo

[edit]

De novo synthesis of ceramide begins with the condensation of palmitate and serine to form 3-keto-dihydrosphingosine. This reaction is catalyzed by the enzyme serine palmitoyl transferase and is the rate-limiting step of the pathway. In turn, 3-keto-dihydrosphingosine is reduced to dihydrosphingosine, which is then followed by acylation by the enzyme (dihydro)ceramide synthase to produce dihydroceramide. The final reaction to produce ceramide is catalyzed by dihydroceramide desaturase. De novo synthesis of ceramide occurs in the endoplasmic reticulum. Ceramide is subsequently transported to the Golgi apparatus by either vesicular trafficking or the ceramide transfer protein CERT. Once in the Golgi apparatus, ceramide can be further metabolized to other sphingolipids, such as sphingomyelin and the complex glycosphingolipids.[3]

Salvage pathway

[edit]

Constitutive degradation of sphingolipids and glycosphingolipids takes place in the acidic subcellular compartments, the late endosomes and the lysosomes, with the end goal of producing sphingosine. In the case of glycosphingolipids, exohydrolases acting at acidic pH optima cause the stepwise release of monosaccharide units from the end of the oligosaccharide chains, leaving just the sphingosine portion of the molecule, which may then contribute to the generation of ceramides. Ceramide can be further hydrolyzed by acid ceramidase to form sphingosine and a free fatty acid, both of which are able to leave the lysosome, unlike ceramide. The long-chain sphingoid bases released from the lysosome may then re-enter pathways for synthesis of ceramide and/or sphingosine-1-phosphate. The salvage pathway re-utilizes long-chain sphingoid bases to form ceramide through the action of ceramide synthase. Thus, ceramide synthase family members probably trap free sphingosine released from the lysosome at the surface of the endoplasmic reticulum or in endoplasmic reticulum-associated membranes. The salvage pathway has been estimated to contribute from 50% to 90% of sphingolipid biosynthesis.[4]

Physiological roles

[edit]

Pathology

[edit]

As a bioactive lipid, ceramide has been implicated in a variety of physiological functions including apoptosis, cell growth arrest, differentiation, cell senescence, cell migration and adhesion.[3] Roles for ceramide and its downstream metabolites have also been suggested in a number of pathological states including cancer, neurodegeneration, diabetes, microbial pathogenesis, obesity, and inflammation.[5][6]

Several distinct ceramides potently predict major adverse cardiovascular events (MACE), namely C16:0, C18:0, and C24:1, although C24:0 has an inverse relationship.[7][8] C16-C18 are harmful in the liver.[7] Ceramide levels are positively correlated with inflammation and oxidative stress in the liver, and the onset and progression of non-alcoholic fatty liver disease (NAFLD) is associated with elevated ceramide in hepatocytes.[8] Dietary intake of saturated fat has been shown to increase serum ceramide and increase insulin resistance.[7] Although initial studies showed increased insulin resistance in muscle, subsequent studies also showed increased insulin resistance in liver and adipose tissue.[8] Interventions that limit ceramide synthesis or increase ceramide degradation lead to improved health (reduced insulin resistance and reduced fatty liver disease, for example).[7]

Ceramides induce skeletal muscle insulin resistance when synthesized as a result of saturated fat activation of TLR4 receptors.[9] Unsaturated fat does not have this effect.[9] Ceramides induce insulin resistance in many tissues by inhibition of Akt/PKB signaling.[10] Aggregation of LDL cholesterol by ceramide causes LDL retention in arterial walls, leading to atherosclerosis.[11] Ceramides cause endothelial dysfunction by activating protein phosphatase 2 (PP2A).[12] In mitochondria, ceramide suppresses the electron transport chain and induces production of reactive oxygen species.[13]

Apoptosis

[edit]

One of the most studied roles of ceramide pertains to its function as a proapoptotic molecule. Apoptosis, or Type I programmed cell death, is essential for the maintenance of normal cellular homeostasis and is an important physiological response to many forms of cellular stress. Ceramide accumulation has been found following treatment of cells with a number of apoptotic agents, including ionizing radiation,[2][14] UV light,[15] TNF-alpha,[16] and chemotherapeutic agents. This suggests a role for ceramide in the biological responses of all these agents. Because of its apoptosis-inducing effects in cancer cells, ceramide has been termed the "tumor suppressor lipid". Several studies have attempted to define further the specific role of ceramide in the events of cell death and some evidence suggests ceramide functions upstream of the mitochondria in inducing apoptosis. However, owing to the conflicting and variable nature of studies into the role of ceramide in apoptosis, the mechanism by which this lipid regulates apoptosis remains elusive.[17]

Skin

[edit]

The stratum corneum is the outermost layer of the epidermis.[18][19][20] It is composed of terminally differentiated and enucleated corneocytes that reside within a lipid matrix, like "bricks and mortar." Together with cholesterol and free fatty acids, ceramides form the lipid mortar, a water-impermeable barrier that prevents evaporative water loss. As a rule of thumb, the epidermal lipid matrix is composed of an equimolar mixture of ceramides (~50% by weight), cholesterol (~ 25% by weight), and free fatty acids (~15% by weight), with smaller quantities of other lipids also being present.[21][22] The lipid barrier also protects against the entry of microorganisms.[20]

Epidermal ceramides have a diversity of structures and can be broadly classified as AS and NS ceramides; ADS and NDS dihydroceramides; AH, EOH, and NH 6-hydroxyceramides; AP and NP phytoceramides; and EOH and EOS acylceramides, see figure.

Epidermal Ceramides. (Merleev et al., JCI Insight 2022, Supplemental Data p.14- Supplemental Fig. 1)

[18] The diversity of ceramide structures undoubtedly plays an important role in the unique attributes of the stratum corneum across different body sites. For example, the stratum corneum of the face is thin and flexible to accommodate different facial expressions. In contrast, the stratum corneum covering the heel of the foot is thick and rigid to protect against trauma. Matching these structural changes, there are body-site specific alterations in the epidermal lipidome, including changes in the relative abundance of the different epidermal ceramide structures.[18]

Similar to body site-specific alterations in ceramide abundance, there are also well-characterized changes in epidermal ceramide expression in patients with inflammatory skin diseases. In the hyperplastic disorder psoriasis, investigators have reported an increase in AS and NS ceramides and a decrease in EOS, AP, and NP ceramides, which may contribute to a defect in the skin's water impermeability barrier.[23][24][22] Studying ceramide expression in atopic dermatitis and psoriasis patients, other investigators have reported that rather than focusing on ceramide classes, ceramide sphingoid base length and fatty acid chain length have the strongest influence on the likelihood of a particular ceramide structure being upregulated or downregulated in inflamed skin.[18] Ceramide levels in the skin, hair, and nails can be reduced due to environmental changes (such as dry/polluted air), use of harsh sulfates, excessive heat (including heat styling), UV exposure, and biological aging.[25]

Hormonal

[edit]

Inhibition of ceramide synthesis with myriocin in obese mice may lead to both improved leptin signaling and decreased insulin resistance by decreasing SOCS-3 expression.[26] An elevated level of ceramide can cause insulin resistance by inhibiting the ability of insulin to activate the insulin signal transduction pathway and/or via the activation of JNK.[27]

Substances known to induce ceramide generation

[edit]

Mechanism by which ceramide signaling occurs

[edit]

Currently, the means by which ceramide acts as a signaling molecule are not clear.

One hypothesis is that ceramide generated in the plasma membrane enhances membrane rigidity and stabilizes smaller lipid platforms known as lipid rafts, allowing them to serve as platforms for signalling molecules. Moreover, as rafts on one leaflet of the membrane can induce localized changes in the other leaflet of the bilayer, they can potentially serve as the link between signals from outside the cell to signals to be generated within the cell.

Ceramide has also been shown to form organized large channels traversing the mitochondrial outer membrane. This leads to the egress of proteins from the intermembrane space.[33][34][35]

[edit]

In the metabolic disease combined malonic and methylmalonic aciduria (CMAMMA) due to ACSF3, a massive altered composition of complex lipids occurs as a result of impaired mitochondrial fatty acid synthesis (mtFAS).[36][37] For example, while the concentration of sphingomyelin is noticeably increased, the concentration of ceramides is proportionally decreased.[36]

Uses

[edit]

Ceramides may be found as ingredients of some topical skin medications used to complement treatment for skin conditions such as eczema.[38] They are also used in cosmetic products such as some soaps, shampoos, skin creams, and sunscreens.[39] Additionally, ceramides are being explored as a potential therapeutic in treating cancer.[40]

Ceramide in bacteria

[edit]

Ceramide is rarely found in bacteria.[41] Bacteria of family Sphingomonadaceae, however, contain it.

Ceramide phosphoethanolamine

[edit]

Ceramide phosphoethanolamine (CPE) is a sphingolipid consisted of a ceramide and a phosphoethanolamine head group. CPE is the major sphingolipid class in some invertebrates such as members of Drosophila. In contrast, mammalian cells contain only small amounts of CPE.

References

[edit]
  1. ^ Davis, Deanna; Kannan, Muthukumar; Wattenberg, Binks (2018-12-01). "Orm/ORMDL proteins: Gate guardians and master regulators". Advances in Biological Regulation. Sphingolipid Signaling in Chronic Disease. 70: 3–18. doi:10.1016/j.jbior.2018.08.002. ISSN 2212-4926. PMC 6251742. PMID 30193828.
  2. ^ a b c Haimovitz-Friedman A, Kan CC, Ehleiter D, et al. (1994). "Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis". J. Exp. Med. 180 (2): 525–35. doi:10.1084/jem.180.2.525. PMC 2191598. PMID 8046331.
  3. ^ a b Hannun, Y.A.; Obeid, L.M. (2008). "Principles of bioactive lipid signalling: lessons from sphingolipids". Nature Reviews Molecular Cell Biology. 9 (2): 139–150. doi:10.1038/nrm2329. PMID 18216770. S2CID 8692993.
  4. ^ Kitatani K, Idkowiak-Baldys J, Hannun YA (2008). "The sphingolipid salvage pathway in ceramide metabolism and signaling". Cell Signaling. 20 (6): 1010–1018. doi:10.1016/j.cellsig.2007.12.006. PMC 2422835. PMID 18191382.
  5. ^ Zeidan, Y.H.; Hannun, Y.A. (2007). "Translational aspects of sphingolipid metabolism". Trends Mol. Med. 13 (8): 327–336. doi:10.1016/j.molmed.2007.06.002. PMID 17588815.
  6. ^ Wu D, Ren Z, Pae M, Guo W, Cui X, Merrill AH, Meydani SN (2007). "Aging up-regulates expression of inflammatory mediators in mouse adipose tissue". The Journal of Immunology. 179 (7): 4829–39. doi:10.4049/jimmunol.179.7.4829. PMID 17878382.
  7. ^ a b c d Tippetts TS, Holland WL, Summers SA (2021). "Cholesterol - the devil you know; ceramide - the devil you don't". Trends in Pharmacological Sciences. 42 (12): 1082–1095. doi:10.1016/j.tips.2021.10.001. PMC 8595778. PMID 34750017.
  8. ^ a b c Zhu C, Huai Q, Zhang X, Dai H, Li X, Wang H (2023). "Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease". International Journal of Biological Sciences. 19 (1): 311–330. doi:10.7150/ijbs.78525. PMC 9760443. PMID 36594091.
  9. ^ a b Holland WL, Bikman BT, Wang LP, Yuguang G, Sargent KM, Bulchand S, Knotts TA, Shui G, Clegg DJ, Wenk MR, Pagliassotti MJ, Scherer PE, Summers SA (2011). "Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice". Journal of Clinical Investigation. 121 (5): 1858–1870. doi:10.1172/JCI43378. PMC 3083776. PMID 21490391.
  10. ^ Chavez JA, Siddique MM, Wang ST, Ching J, Shayman JA, Summers SA (2014). "Ceramides and glucosylceramides are independent antagonists of insulin signaling". Journal of Biological Chemistry. 289 (2): 723–734. doi:10.1074/jbc.M113.522847. PMC 3887200. PMID 24214972.
  11. ^ Li Z, Basterr MJ, Hailemariam TK, Hojjati MR, Lu S, Liu J, Liu R, Zhou H, Jiang XC (2005). "The effect of dietary sphingolipids on plasma sphingomyelin metabolism and atherosclerosis". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1735 (2): 130–134. doi:10.1016/j.bbalip.2005.05.004. PMID 15967715.
  12. ^ Mehra VC, Jackson E, Zhang XM, Jiang XC, Dobrucki LW, Yu J, Bernatchez P, Sinusas AJ, Shulman GI, Sessa WC, Yarovinsky TO, Bender JR (2014). "Ceramide-activated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesis". The American Journal of Pathology. 184 (5): 1562–1576. doi:10.1016/j.ajpath.2014.01.009. PMC 4005977. PMID 24606881.
  13. ^ Kogot-Levin A, Saada A (2014). "Ceramide and the mitochondrial respiratory chain". Biochimie. 100: 88–94. doi:10.1016/j.biochi.2013.07.027. PMID 23933096.
  14. ^ Dbaibo GS, Pushkareva MY, Rachid RA, Alter N, Smyth MJ, Obeid LM, Hannun YA (1998). "p53-dependent ceramide response to genotoxic stress". J. Clin. Invest. 102 (2): 329–339. doi:10.1172/JCI1180. PMC 508891. PMID 9664074.
  15. ^ Rotolo JA, Zhang J, Donepudi M, Lee H, Fuks Z, Kolesnick R (2005). "Caspase-dependent and -independent activation of acid sphingomyelinase signaling". J. Biol. Chem. 280 (28): 26425–34. doi:10.1074/jbc.M414569200. PMID 15849201.
  16. ^ Dbaibo GS, El-Assaad W, Krikorian A, Liu B, Diab K, Idriss NZ, El-Sabban M, Driscoll TA, Perry DK, Hannun YA (2001). "Ceramide generation by two distinct pathways in tumor necrosis factor alpha-induced cell death". FEBS Letters. 503 (1): 7–12. doi:10.1016/S0014-5793(01)02625-4. PMID 11513845. S2CID 85367540.
  17. ^ Taha TA, Mullen TD, Obeid LM (2006). "A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death". Biochimica et Biophysica Acta (BBA) - Biomembranes. 1758 (12): 2027–36. doi:10.1016/j.bbamem.2006.10.018. PMC 1766198. PMID 17161984.
  18. ^ a b c d Merleev, AA; Le, ST; Alexanian, C; Toussi, A; Xie, Y; Marusina, AI; Watkins, SM; Patel, F; Billi, AC; Wiedemann, J; Izumiya, Y; Kumar, A; Uppala, R; Kahlenberg, JM; Liu, FT; Adamopoulos, IE; Wang, EA; Ma, C; Cheng, MY; Xiong, H; Kirane, A; Luxardi, G; Andersen, B; Tsoi, LC; Lebrilla, CB; Gudjonsson, JE; Maverakis, E (22 August 2022). "Biogeographic and disease-specific alterations in epidermal lipid composition and single-cell analysis of acral keratinocytes". JCI Insight. 7 (16). doi:10.1172/jci.insight.159762. PMC 9462509. PMID 35900871.
  19. ^ Hill JR, Wertz PW (2009). "Structures of the ceramides from porcine palatal stratum corneum". Lipids. 44 (3): 291–295. doi:10.1007/s11745-009-3283-9. PMID 19184160. S2CID 4005575.
  20. ^ a b Garidel P, Fölting B, Schaller I, Kerth A (2010). "The microstructure of the stratum corneum lipid barrier: mid-infrared spectroscopic studies of hydrated ceramide:palmitic acid:cholesterol model systems". Biophysical Chemistry. 150 (1–3): 144–156. doi:10.1016/j.bpc.2010.03.008. PMID 20457485.
  21. ^ Elias, Peter (2006). Skin barrier. New York: Taylor & Francis. ISBN 9780824758158.
  22. ^ a b Feingold KR (2007). "Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis". Journal of Lipid Research. 48 (12): 2531–2546. doi:10.1194/jlr.R700013-JLR200. PMID 17872588.
  23. ^ Motta, S; Monti, M; Sesana, S; Caputo, R; Carelli, S; Ghidoni, R (8 September 1993). "Ceramide composition of the psoriatic scale". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1182 (2): 147–51. doi:10.1016/0925-4439(93)90135-n. PMID 8357845.
  24. ^ Merleev, Alexander A.; Le, Stephanie T.; Alexanian, Claire; Toussi, Atrin; Xie, Yixuan; Marusina, Alina I.; Watkins, Steven M.; Patel, Forum; Billi, Allison C.; Wiedemann, Julie; Izumiya, Yoshihiro; Kumar, Ashish; Uppala, Ranjitha; Kahlenberg, J. Michelle; Liu, Fu-Tong; Adamopoulos, Iannis E.; Wang, Elizabeth A.; Ma, Chelsea; Cheng, Michelle Y.; Xiong, Halani; Kirane, Amanda; Luxardi, Guillaume; Andersen, Bogi; Tsoi, Lam C.; Lebrilla, Carlito B.; Gudjonsson, Johann E.; Maverakis, Emanual (22 August 2022). "Biogeographic and disease-specific alterations in epidermal lipid composition and single-cell analysis of acral keratinocytes". JCI Insight. 7 (16). doi:10.1172/jci.insight.159762. PMC 9462509. PMID 35900871.
  25. ^ Coderch, Luisa, et al. "Ceramides and skin function." American journal of clinical dermatology 4 (2003): 107-129.
  26. ^ Yang G, Badeanlou L, Bielawski J, Roberts AJ, Hannun YA, Samad F (2009). "Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome". American Journal of Physiology. 297 (1): E211–E224. doi:10.1152/ajpendo.91014.2008. PMC 2711669. PMID 19435851.
  27. ^ Febbraio, Mark (2014). "Role of interleukins in obesity:implications for metabolic disease". Trends in Endocrinology and Metabolism. 25 (6): 312–319. doi:10.1016/j.tem.2014.02.004. PMID 24698032. S2CID 27123917.
  28. ^ a b c d Bismuth J, Lin P, Yao Q, Chen C (2008). "Ceramide: a common pathway for atherosclerosis?". Atherosclerosis. 196 (2): 497–504. doi:10.1016/j.atherosclerosis.2007.09.018. PMC 2924671. PMID 17963772.
  29. ^ Whitney P. Bowe; Leon H. Kircik (August 2014). "The Importance of Photoprotection and Moisturization in Treating Acne Vulgaris". Journal of Drugs in Dermatology. 13 (8): 89. Archived from the original on 2022-01-02. Retrieved 2022-01-02.
  30. ^ "Hydroxypalmitoyl Sphinganine (Explained + Products)". incidecoder.com. Archived from the original on 12 July 2021. Retrieved 12 July 2021.
  31. ^ Hallahan DE (1996). "Radiation-mediated gene expression in the pathogenesis of the clinical radiation response". Sem. Radiat. Oncol. 6 (4): 250–267. doi:10.1016/S1053-4296(96)80021-X. PMID 10717183.
  32. ^ Velasco, G; Galve-Roperh, I; Sánchez, C; Blázquez, C; Haro, A; Guzmán, M (2005). "Cannabinoids and ceramide: Two lipids acting hand-by-hand". Life Sciences. 77 (14): 1723–31. doi:10.1016/j.lfs.2005.05.015. PMID 15958274.
  33. ^ Siskind LJ, Kolesnick RN, Colombini M (2002). "Ceramide Channels Increase the Permeability of the Mitochondrial Outer Membrane to Small Proteins". J. Biol. Chem. 277 (30): 26796–803. doi:10.1074/jbc.M200754200. PMC 2246046. PMID 12006562.
  34. ^ Stiban J, Fistere D, Colombini M (2006). "Dihydroceramide hinders ceramide channel formation: Implications on apoptosis". Apoptosis. 11 (5): 773–80. doi:10.1007/s10495-006-5882-8. PMID 16532372. S2CID 12633095.
  35. ^ Siskind LJ, Kolesnick RN, Colombini M (2006). "Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations". Mitochondrion. 6 (3): 118–25. doi:10.1016/j.mito.2006.03.002. PMC 2246045. PMID 16713754.
  36. ^ a b Wehbe, Zeinab; Behringer, Sidney; Alatibi, Khaled; Watkins, David; Rosenblatt, David; Spiekerkoetter, Ute; Tucci, Sara (2019-11-01). "The emerging role of the mitochondrial fatty-acid synthase (mtFASII) in the regulation of energy metabolism". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1864 (11): 1629–1643. doi:10.1016/j.bbalip.2019.07.012. ISSN 1388-1981. PMID 31376476.
  37. ^ Tucci, Sara (2020-01-22). "Brain metabolism and neurological symptoms in combined malonic and methylmalonic aciduria". Orphanet Journal of Rare Diseases. 15 (1): 27. doi:10.1186/s13023-020-1299-7. ISSN 1750-1172. PMC 6977288. PMID 31969167.
  38. ^ "Ceramides - Skin Lipids That Keep Skin Moisturized". Archived from the original on 6 April 2016. Retrieved 29 January 2015.
  39. ^ "Safety Assessment of Ceramides as Used in Cosmetics" (PDF). Cosmetic Ingredient Review. May 16, 2014. Archived (PDF) from the original on January 13, 2021. Retrieved August 26, 2015. {{cite journal}}: Cite journal requires |journal= (help)
  40. ^ Huang, WC; Chen, CL; Lin, YS; Lin, CF (2011). "Apoptotic Sphingolipid Ceramide in Cancer Therapy". Journal of Lipids. 2011 (2011): 565316. doi:10.1155/2011/565316. PMC 3066853. PMID 21490804.
  41. ^ Minamino, Miki; Sakaguchi, Ikuyo; Naka, Takashi; Ikeda, Norikazu; Kato, Yoshiko; Tomiyasu, Ikuko; Yano, Ikuya; Kobayashi, Kazuo (2003). "Bacterial ceramides and sphingophospholipids induce apoptosis of human leukaemic cells". Microbiology. 149 (8): 2071–2081. doi:10.1099/mic.0.25922-0. PMID 12904547.
[edit]
Scholia has a chemical-class profile for Ceramide.
Retrieved from "https://wiki.riteme.site/w/index.php?title=Ceramide&oldid=1255871267#Apoptosis"